Wockhardt Limited


$613.6 INR

$10.1 (1.67%)

Average Volume
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
Year High
Year Low
Payout Ratio
Current Ratio

Industry, Sector & symbol

Stock Exchange Bombay Stock Exchange
CEO Dr. Habil Fakhruddin Khorakiwala
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Current Symbol WOCKPHARMA.BO
CIK None
Web https://www.wockhardt.com
Phone 91 24 0669 4444
Currency INR
Employees 2740
Country IN


Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 0.00
Quick Ratio 0.00
Cash Ratio 0.00

Sales & Book Value

Annual Sales $26.46B
Price / Sales 3.19
Cash Flow -21.41
Price / Cash Flow -28.62
Price / Book 0.00

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts


EPS (Most Recent Fiscal Year) $-38.74
Trailing P/E Ratio -10.79
PEG Ratio 0.12
P/E Growth 0.12
Net Income $-5.59B
Net Margin -29.63%
Pretax Margin -15.63%
Return on Equity -50.69%
Return on Assets 0.00%

Financials Score

AltmanZ Score
Piotroski Score 4.00
Working Capital -
Total Assets -
Ebit -260M
Market Cap 88.43B
Total Liabilities -

Poll Results

About Wockhardt Limited (BSE:WOCKPHARMA.BO) Stock

Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, a ... nd delivery devices. It also provides contract manufacturing services. The company was founded in 1967 and is headquartered in Mumbai, India.

Frequently Asked Questions

What is the current Wockhardt Limited (WOCKPHARMA.BO) stock price?

Wockhardt Limited(BSE:WOCKPHARMA.BO) stock price is $613.6 in the last trading session. During the trading session, WOCKPHARMA.BO stock reached the peak price of $630.0 while $145.35 was the lowest point it dropped to. The percentage change in WOCKPHARMA.BO stock occurred in the recent session was 1.67% while the dollar amount for the price change in WOCKPHARMA.BO stock was $10.1.

WOCKPHARMA.BO's industry and sector of operation?

The BSE listed WOCKPHARMA.BO is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of WOCKPHARMA.BO?

Dr. Lalit Aggarwal | President of Manufacturing
Mr. Zoher T. Sihorwala | Head of Global Regulatory Affairs
Mr. Deepak Madnani | Chief Financial Officer
Mr. Neeraj Agarwal | Chief Human Resource Officer
Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA | Senior Vice President of Business Development

How many employees does WOCKPHARMA.BO have?

Number of WOCKPHARMA.BO employees currently stands at 2740. WOCKPHARMA.BO operates from Wockhardt Towers, Mumbai, None 400051, IN.

Link for WOCKPHARMA.BO official website?

Official Website of WOCKPHARMA.BO is: https://www.wockhardt.com

How do I contact WOCKPHARMA.BO?

WOCKPHARMA.BO could be contacted at phone #91 24 0669 4444 and can also be accessed through its website. WOCKPHARMA.BO operates from Wockhardt Towers, Mumbai, None 400051, IN.

How many shares of WOCKPHARMA.BO are traded daily?

The average number of WOCKPHARMA.BO shares traded daily for last 3 months was 147.37K.

What is the market cap of WOCKPHARMA.BO currently?

The market value of WOCKPHARMA.BO currently stands at $88.43B with its latest stock price at $613.6